Simultaneous Generation of CD8+ and CD4+ Melanoma-Reactive T Cells by Retroviral-Mediated Transfer of a Single T-Cell Receptor

J. Roszkowski(University of Chicago), Michael I. Nishimura(Loyola University Medical Center), Gretchen E. Lyons(University of Chicago), Cassian Yee(The University of Texas MD Anderson Cancer Center), Koen van Besien(University Hospitals of Cleveland), W. Martin Kast(University of Southern California)
Cancer Research
February 15, 2005
10.1158/0008-5472.can-04-2076
Cited by 104

Related Papers

Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
|Blood|1997|1.2k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
|Nature Medicine|1999|1.1k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
|New England Journal of Medicine|2008|903